Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Medicago Plans Vaccine Facility
by Marc S. Reisch
May 25, 2015
| A version of this story appeared in
Volume 93, Issue 21
Medicago, a maker of plant-based vaccines and therapeutics, says it will build a $245 million production complex in Quebec City. To be built in the Estimauville Innovation Park and completed in 2019, the 474,000-sq-ft facility will also house the company’s main office and R&D activities. The facility will enable the firm to hire 200 people in addition to the 180 it already employs in Quebec City.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X